Simon LF Walsh
Chief Scientific Officer Qureight
Simon has over 19 years of experience in Radiology and is currently doing clinical work in London as a Consultant Thoracic Radiologist. He also holds a PhD in Biomedical Imaging, specialising in fibrotic lung diseases following his Fellowship at Royal Brompton and Harefield Hospital Foundation Trust. He was previously a Consultant Thoracic Radiologist at King’s Hospital Foundation Trust. He also has a background in computer science, specialising in machine learning and computer vision. His research focuses on advanced computational imaging analysis and digital biomarker discovery in diffuse lung diseases. He is the past Imaging Chair for the European Respiratory Society and in 2022 was elected to the Fleischner Society, a prestigious global group of leading Respiratory Scientists, Pulmonologists and Radiologists.
Seminars
- Introducing Qureight’s end-to-end imaging ecosystem spanning imaging CRO services, central reads and AI-powered quantitative biomarkers
- Important lessons from recent IPF and PPF studies demonstrating how imaging is improving patient selection, endpoint assessment and trial efficiency
- How integrated imaging and biomarker strategies are shaping the next generation of antifibrotic clinical trials
- Why fibrosis burden is the principal structural imaging biomarker for antifibrotic drug development and the leading candidate imaging endpoint
